Due to the ongoing coronavirus pandemic, the world is short on good news. No matter what happens, there is always bad news related to the pandemic that takes over. This is not unusual, given that the virus has infected nearly 5 million people and killed 316,000 so far.
There are ongoing efforts all across the globe to find a vaccine for the virus. Given that it is an extremely infectious disease, the hopes of returning to normal life without one are almost non-existent.
Some researchers are achieving progress. Moderna, an American biotechnology company, is one of them.
Coronavirus Update – What It’s Like To Be A Grocery Store Essential Worker During The Pandemic
HAS MODERNA SUCCESSFULLY MADE A VACCINATION FOR CORONAVIRUS?
Moderna hasn’t “successfully” made a vaccination for the virus. However, they have made some progress.
The company announced on Monday that their vaccine was able to stimulate an immune response against the virus.
However, these findings are based on the first eight people who were given two doses of the experimental vaccine each.
Moderna produced the vaccine in collaboration with the National Institute of Allergy and Infectious Diseases, the institute led by Dr. Anthony Fauci.
Earlier this month, the company received the nod from the Food and Drug Administration to go forward with its second phase.
Coronavirus Update – How Governments Are Financing Recovery Efforts
According to Dr. Tal Zaks, Moderna’s chief medical officer, they could have the vaccine available for widespread use by late 2020 or early 2021, if all things go as planned.
“With today’s positive interim Phase 1 data and the positive data in the mouse challenge model, the Moderna team continues to focus on moving as fast as safely possible to start our pivotal Phase 3 study in July and, if successful, file a BLA,” said Stéphane Bancel, Chief Executive Officer at Moderna.
Even though it was successful, small scale testing cannot prove the effectiveness of a vaccine. Only long term and large scale testing can do so.